Qiagen NV (XTER:QIA) Shares Outstanding (EOP): 206 Mil (As of Mar. 2026)


XTER:QIA Qiagen NV XTER:QIA
74 GF Score
Price €34.63
GF Value €45.46
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Qiagen NV Shares Outstanding (EOP)?

Qiagen NV XTER:QIA -1.01% 74 Shares Outstanding (EOP) is 206 Mil as of Mar. 2026. GuruFocus rates XTER:QIA with a GF Score™ of 74/100 and a GF Value™ of €45.46 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Qiagen NV's shares outstanding for the quarter that ended in Mar. 2026 was 206 Mil.

Qiagen NV's quarterly shares outstanding increased from Dec. 2025 (206 Mil) to Mar. 2026 (206 Mil). It means Qiagen NV issued new shares from Dec. 2025 to Mar. 2026 .

Qiagen NV's annual shares outstanding increased from Dec. 2024 (205 Mil) to Dec. 2025 (206 Mil). It means Qiagen NV issued new shares from Dec. 2024 to Dec. 2025 .


Qiagen NV  (XTER:QIA) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Qiagen NV Shares Outstanding (EOP) Related Terms


Qiagen NV Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Qiagen NV's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qiagen NV Shares Outstanding (EOP) Chart

Qiagen NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 203.44 204.01 204.45 205.31 206.08

Qiagen NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 205.73 205.99 206.00 206.08 206.25

XTER:QIA vs TWST, CRL, BLLN: Shares Outstanding (EOP) Comparison

For the Diagnostics & Research subindustry, Qiagen NV's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV Shares Outstanding (EOP) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Shares Outstanding (EOP) falls into.


XTER:QIA
74GF Score
Qiagen NV XTER:QIA
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qiagen NV Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 206 Mil mean?
Qiagen NV (XTER:QIA) has a Shares Outstanding (EOP) of 206 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Qiagen NV and its competitors.
Is Qiagen NV's Shares Outstanding (EOP) too high?
Qiagen NV's current Shares Outstanding (EOP) is 206 Mil. Overall, Qiagen NV has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qiagen NV's Shares Outstanding (EOP) compare to TWST and CRL?
Qiagen NV's Shares Outstanding (EOP) of 206 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Diagnostics & Research company?
A good Shares Outstanding (EOP) depends on the Medical Diagnostics & Research industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Qiagen NV and its competitors. Qiagen NV's current Shares Outstanding (EOP) is 206 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qiagen NV stock overvalued right now?
Based on GuruFocus' analysis, Qiagen NV (XTER:QIA) is currently considered Modestly Undervalued. The stock's GF Value™ is €45.46, compared to a current price of €34.63 — trading 23.8% below its estimated fair value. The current Shares Outstanding (EOP) is 206 Mil. Qiagen NV's overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Qiagen NV (XTER:QIA), the current Shares Outstanding (EOP) is 206 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qiagen NV (XTER:QIA) Overvalued in 2026?

Based on GuruFocus' analysis, Qiagen NV stock appears to be undervalued. The current stock price of €34.63 is trading 23.8% below its estimated GF Value™ of €45.46. GuruFocus considers Qiagen NV to be Modestly Undervalued.

Key valuation signals for XTER:QIA:

  • Shares Outstanding (EOP): 206 Mil
  • GF Value™: €45.46 vs. price of €34.63 (23.8% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the XTER:QIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Qiagen NV Business Description

Address Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
74GF Score

Get the complete analysis for XTER:QIA

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.63
Price
€45.46
GF Value